B
Bigfoot Biomedical
Health Tech & Medtech · Milpitas, United States · Founded 2014
A new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes MoreLess
Bigfoot Biomedical is a pioneering company in the diabetes care market, focusing on innovative solutions for individuals requiring insulin. The company operates in the healthcare technology sector, specifically targeting people with Type 1 and Type 2 diabetes who need insulin therapy. Bigfoot Biomedical's primary offering is a comprehensive digital drug delivery platform that simplifies and optimizes insulin management. This platform is designed to be user-friendly and is experienced as a service, meaning it provides ongoing support and monitoring rather than just a one-time product.
Bigfoot's business model revolves around partnering with healthcare providers to deliver these solutions. By integrating their technology with healthcare services, they enable remote physiologic monitoring (RPM), which allows healthcare professionals to track patients' health data remotely. This approach not only improves patient outcomes but also reduces the burden on healthcare providers by making diabetes management more efficient and accessible.
The company generates revenue through a subscription-based model, where clients—primarily healthcare providers and patients—pay for the continuous use of Bigfoot's digital platform and associated services. This model ensures a steady income stream while providing ongoing value to users.
Bigfoot Biomedical's mission is to change the paradigm of diabetes care by focusing on simplicity, ease of use, and broadening access to effective insulin management solutions. Their goal is to reduce the daily burden of diabetes for a large population, improve health equity, and support healthcare providers in delivering optimal care.
The company is based in Silicon Valley and boasts a team of experts from various fields, including medical technology, enterprise software, and consumer technology. This diverse expertise allows Bigfoot to tackle the complex challenges of diabetes care with innovative and effective solutions.
Keywords: diabetes care, insulin therapy, digital platform, remote monitoring, healthcare technology, patient support, health equity, subscription model, Silicon Valley, innovative solutions.
Company overview
Bigfoot Biomedical company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Milpitas, United States
- Employees
- 66
- Open positions
- 1
- Dealroom signal
- 29.9
- Investment activity
- 2 companies · latest Jun 2017
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Bigfoot Biomedical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2023 | $0 | — | Abbott | ↗ |
| CONVERTIBLEOther financing | Aug 2022 | $0 | — | Undisclosed | — |
| DEBTDebt | Mar 2021 | $29M | — | Madryn Asset Management | — |
| LATE VCOther financing | Mar 2021 | $29M | $114M | Madryn Asset Management | — |
| SERIES COther financing | Jun 2020 | $10M | $40M | Senvest Capital · Cormorant Asset Management · Smile Group · Abbott | — |
| SERIES COther financing | Jan 2020 | Senvest Capital · Janus Henderson Investors · Cormorant Asset Management · Quadrant Capital Advisors | — | ||
| SERIES BOther financing | Aug 2018 | Visionnaire Ventures · JDRF T1D Fund · Senvest Capital · Janus Capital Group | — | ||
| SERIES BOther financing | Mar 2018 | Cormorant Asset Management · Visionnaire Ventures · JDRF T1D Fund · Senvest Capital | — | ||
| SERIES BOther financing | Dec 2017 | Visionnaire Ventures · JDRF T1D Fund · Quadrant Capital Advisors · Janus Capital Group | — | ||
| SERIES AOther financing | Oct 2016 | Jeffrey Brewer · Senvest Capital · Cormorant Asset Management · Quadrant Capital Advisors | — |
Growth signals
Bigfoot Biomedical website traffic
Latest recorded traffic for Bigfoot Biomedical is 1.6K monthly website visits, down 55.6% over the last three months. Bigfoot Biomedical's team declined 53.2% over the past year.
Comparisons
Bigfoot Biomedical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Bigfoot Biomedical investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
TimesulinLondon, United KingdomTimesulin Is a Smart #Timer Cap That Fits Onto Your #Insulin Pen. We make products, advocate and lecture to make living with #diabetes just a little easier.
→
Asante SolutionsSunnyvale, United StatesInnovative insulin delivery systems enhancing diabetes care with smart technology and data-driven solutions
→
Talent graph
Bigfoot Biomedical's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Bigfoot Biomedical has talent and traffic
team presence
In the news
Latest news about Bigfoot Biomedical
Recent press, funding announcements, and product moves mentioning Bigfoot Biomedical — open to read from the original sources.
Market sentiment
What the market is saying about Bigfoot Biomedical
An AI-synthesized read of the highest-engagement posts about Bigfoot Biomedical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bigfoot Biomedical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.